In primates, treatment with PTH (1-34), LY333334, increases bone strength at trabecular bone sites without compromising the strength of cortical bone.

被引：0
|
作者：
Turner, CH
Wang, T
Hirano, T
Burr, DB
Hock, JM
Hotchkiss, CE
Brommage, R
Jerome, CP
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Lilly Res Labs, Indianapolis, IN USA
[3] Wake Forest Univ, Winston Salem, NC 27109 USA
[4] SkeleTech, Bothell, WA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA421
引用
收藏
页码：S414 / S414
页数：1
相关论文
共 50 条
  • [1] In monkeys, treatment with PTH(1-34), LY333334, increases bone strength in lumbar vertebrae and the femoral neck without compromising cortical bone strength
    Turner, CH
    Wang, T
    Hirano, T
    Burr, DB
    Hock, JM
    Hotchkiss, CE
    Brommage, R
    Jerome, CP
    [J]. SIROT 99, 1999, : 107 - 110
  • [2] Effects of LY333334 [recombinant parathyroid hormone (1-34)] on cortical bone strength indices as assessed by peripheral quantitative computed tomography.
    Zanchetta, JR
    Bogado, C
    Ferretti, JL
    Wang, O
    Sato, M
    Gaich, GA
    [J]. BONE, 2001, 28 (05) : S86 - S86
  • [3] Early effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 804 - 804
  • [4] Redistribution of vertebral bone mineral density after transient administration of recombinant human PTH(1-34), LY333334, in monkeys
    Turner, CH
    Hannum, B
    Gurdogan, O
    Clendenon, J
    Sato, M
    [J]. SIROT 99, 1999, : 721 - 724
  • [5] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys
    Brommage, R
    Hotchkiss, CE
    Lees, CJ
    Stancill, MW
    Hock, JM
    Jerome, CP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3757 - 3763
  • [6] Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. BONE, 2001, 28 (05) : 538 - 547
  • [7] Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits
    Hirano, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (04) : 536 - 545
  • [8] PTH[1-34], but not alendronate, increases bone quality in trabecular bone in a rat model of osteoporosis.
    Jorgensen, N. R.
    Thorkildsen, C.
    Jensen, J. B.
    Petersen, J. S.
    Schwarz, P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S297 - S297
  • [9] The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys
    Turner, CH
    Burr, DB
    Hock, JM
    Brommage, R
    Sato, M
    [J]. NONINVASIVE ASSESSMENT OF TRABECULAR BONE ARCHITECTURE AND THE COMPETENCE OF BONE, 2001, 496 : 165 - 179
  • [10] HUMAN PARATHYROID HORMONE(1-34) INCREASES BONE-FORMATION AND STRENGTH OF CORTICAL BONE IN AGED RATS
    EJERSTED, C
    ANDREASSEN, TT
    NILSSON, MHL
    OXLUND, H
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (02) : 201 - 207
12345